Schnitzer TJ, et al. Efficacy and Safety of Subcutaneous Tanezumab for the Treatment of Osteoarthritis of the Hip or Knee. ACR 2018, abstract L20.
Dosisverlaging van rituximab effectief in klinische praktijk
aug 2024 | RA
nov 2022 | Psoriasis
nov 2020
okt 2020
aug 2020 | RA, SLE